{
    "clinical_study": {
        "@rank": "119204", 
        "arm_group": {
            "arm_group_label": "tamsulosin hydrochloride", 
            "arm_group_type": "Experimental", 
            "description": "patients will take drug for 8 weeks in this exploratory study"
        }, 
        "brief_summary": {
            "textblock": "Multicenter trial conducted in Pharmacy retail centers"
        }, 
        "brief_title": "An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Lower Urinary Tract Symptoms", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. Men 18 years of age and older.\n\n          2. Able to speak, read and understand English.\n\n          3. Willing to participate in the study and voluntarily sign an informed consent\n             document.\n\n        Exclusion criteria:\n\n        1.  Subject or anyone in their household is currently employed by a marketing or marketing\n        research company, and advertising agency or public relations firm, a pharmacy or\n        pharmaceutical company, a manufacturer of medicines, a managed care or health insurance\n        company as a healthcare professional or healthcare practice."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "689", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726270", 
            "org_study_id": "527.82"
        }, 
        "intervention": {
            "arm_group_label": "tamsulosin hydrochloride", 
            "description": "0.4 mg", 
            "intervention_name": "tamsulosin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Tamsulosin"
        }, 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hoover", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "527.82.170 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mesa", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "527.82.167 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Encino", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "527.82.177 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Garden Grove", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "527.82.168 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Habra", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "527.82.171 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anoka", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "527.82.161 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elk River", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "527.82.179 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fridley", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "527.82.163 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roseville", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "527.82.165 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Francis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "527.82.166 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico"
                    }, 
                    "name": "527.82.176 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Longview", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "527.82.181 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tyler", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "527.82.160 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bountiful", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "527.82.162 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Layton", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "527.82.180 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "527.82.173 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "527.82.174 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "527.82.169 Boehringer Ingelheim Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary objective was to collect preliminary self-reported behavioral data on actual use of the product that will inform the design of a pivotal Actual Use study.", 
            "safety_issue": "No", 
            "time_frame": "<please enter timeframe>"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726270"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}